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The Src substrate associated in mitosis of 68 kDa (Sam68) is a KH-type RNA binding protein that has been shown to
regulate several aspects of RNA metabolism; however, its physiologic role has remained elusive. Herein we report the
generation of Sam68-null mice by homologous recombination. Aged Sam68
 /  mice preserved their bone mass, in
sharp contrast with 12-month-old wild-type littermates in which bone mass was decreased up to approximately 75%.
In fact, the bone volume of the 12-month-old Sam68
 /  mice was virtually indistinguishable from that of 4-month-old
wild-type or Sam68
 /  mice. Sam68
 /  bone marrow stromal cells had a differentiation advantage for the osteogenic
pathway. Moreover, the knockdown of Sam68 using short hairpin RNA in the embryonic mesenchymal multipotential
progenitor C3H10T1/2 cells resulted in more pronounced expression of the mature osteoblast marker osteocalcin when
differentiation was induced with bone morphogenetic protein-2. Cultures of mouse embryo fibroblasts generated from
Sam68
þ/þ and Sam68
 /  littermates were induced to differentiate into adipocytes with culture medium containing
pioglitazone and the Sam68
 /  mouse embryo fibroblasts shown to have impaired adipocyte differentiation.
Furthermore, in vivo it was shown that sections of bone from 12-month-old Sam68
 / mice had few marrow adipocytes
compared with their age-matched wild-type littermate controls, which exhibited fatty bone marrow. Our findings
identify endogenous Sam68 as a positive regulator of adipocyte differentiation and a negative regulator of osteoblast
differentiation, which is consistent with Sam68 being a modulator of bone marrow mesenchymal cell differentiation,
and hence bone metabolism, in aged mice.
Citation: Richard S, Torabi N, Franco GV, Tremblay GA, Chen T, et al. (2005) Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss. PLoS Genet
1(6): e74.
Introduction
During skeletal development, the anabolic activity of
osteoblasts [1] is favored over the catabolic activity of
osteoclasts [2], which results in a net gain in bone mass. At
skeletal maturity, bone mass is maintained through the
balanced activity of osteoblasts and osteoclasts during the
remodeling cycle. During skeletal aging, there is a shift in the
balance that favors osteoclast over osteoblast activity, which
results in net bone loss [3]. The amount and rate at which
bone is gained during development and lost during aging are
determined in large part by genetics [4–6] but also by physical
activity and by alterations in the availability and response of
bone cells to circulating hormones [7–9] and locally derived
growth factors [10,11]. Whereas genetic-based studies have
provided novel insights into the pathways that regulate bone
development [12–14], relatively little is known about the
etiology of age-related bone loss. Increased bone resorption
in elderly men and women is associated with a reduction in
bone mass and an increase in circulating levels of bone
biomarkers [15]. These changes have been attributed primar-
ily to nutritional deﬁcits resulting in alterations in the
parathyroid hormone–vitamin D axis [16], to gonadal
hormone deﬁciency [17], to leptin levels and the sympathetic
nervous system [8,18–20], and to alterations in bone cell
apoptosis [21]. Bone loss in the elderly has also been
attributed to alterations in the response of bone marrow
stromal cells to their microenvironment that favors differ-
entiation down the adipocyte lineage rather than the
osteoblast lineage [22].
Aging has long been associated with an increase in marrow
fat, where the generation of adipocytes is favored over
osteoblasts [23]. Osteoblasts and adipocytes are derived from
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marrow, and the factors that control this age-induced switch
toward adipogenic differentiation is not well understood [24].
While several transcriptional regulatory proteins have been
associated with cell fate determination of bone marrow
mesenchymal cells, including peroxisome proliferator–acti-
vated receptor c (PPARc) and KLF5 [25–30], the role of RNA
binding proteins in this process remains unknown. RNA
binding proteins of the KH type are known regulators of
cellular differentiation. For example, expression defects in
the KH domain proteins NOVA and FMRP are known to
cause paraneoplastic neurologic disorders [31] and the fragile
X syndrome, respectively, in humans [32]. The phenotype of
the quaking viable mice suggests a role for the QUAKING RNA
binding protein in oligodendrocytes and myelination [33].
Indeed, the ectopic expression of the QKI-6/7 isoforms in vivo
led to the formation of glial cells rather than neurons from
neural progenitor, demonstrating its role in cell fate
determination [34]. The loss of GLD-1 protein in Caenorhab-
ditis elegans prevents the appearance of stem cells [35], and the
absence of the KH domain protein HOW in Drosophila
prevents muscle differentiation and results in ﬂies with
held-out-wings [36,37]. The Src substrate associated in mitosis
of 68 kDa (Sam68) is also a member of the family of KH
domain RNA binding proteins [38]; however, its physiologic
role has remained undeﬁned.
Sam68 was identiﬁed as an SH3 and SH2 domain
interacting protein for Src family kinases and is also a known
substrate of Src kinases [39–42] and of the breast tumor
kinase [43]. Sam68 has been shown to facilitate the export of
unspliced HIV RNA [44] and to regulate pre-mRNA process-
ing [45]. In the present paper, we report the generation of
Sam68
 /  mice and analysis of their skeletal phenotype. Our
data indicate that the absence of Sam68 confers resistance to
age-related bone loss in mice such that old Sam68 have a
higher bone mass than their wild-type littermates. We
provide evidence that Sam68 regulates the differentiation
of bone marrow stromal cells by showing that cells isolated
from Sam68
 /  animals had enhanced osteogenic activity and
decreased adipogenic activity than those harvested from wild-
type littermates. Furthermore, Sam68
 /  mouse embryo
ﬁbroblasts (MEFs) were impaired in their capacity to differ-
entiate into adipocytes, consistent with Sam68 being a
regulator of bone marrow mesenchymal cell differentiation.
These results also characterize a new animal model to study
bone metabolism, regeneration, and repair during aging.
Results
Sam68 Is Expressed in the Developing Skeleton of
Embryonic Mice
The Sam68 mRNA is known to be widely expressed [38],
whereas its pattern of protein expression in vivo remains to
be deﬁned. Sections of parafﬁn-embedded wild-type E14.5
and E16.5 embryonic mice were immunostained with the
well-characterized AD1 anti-Sam68 antibody, raised in
rabbits against an immunizing peptide that corresponds to
amino acids 330 to 348 of the mouse Sam68 protein [46].
Sam68 immunoreactivity was observed in the skeleton and
soft tissues of developing wild-type mice at E14.5 and E16.5
(Figure 1). Intense staining was seen in the nucleus of cells
in the developing brain, heart, and small intestine (Figure
1B), as well as in chondrocytes in the nasal septum and the
glandular tissue adjacent to the nasal cartilage (Figure 1C,
panels A–D), in the vertebra and intervertebral discs (panels
E–H) and in the epiphysis (panels I–K) and metaphysis
(panel L) of long bones. Nuclear staining was observed in
proliferating chondrocytes and hypertrophic chondrocytes
(Figure 1C, panel H), in osteoblasts (panel L; Dataset S1),
and in osteoclasts (Dataset S1). No staining was observed
with preimmune serum or when the antiserum was
preadsorbed with the immunizing peptide (Figure 1C, panels
B, F, and J). Taken together, these data demonstrate that
Sam68 protein is selectively expressed in the developing
mouse embryo, with particularly elevated expression in
cartilage and bone.
Sam68 is Not Essential for Mouse Development
To deﬁne the physiologic role of Sam68, we generated
Sam68-deﬁcient mice by targeted disruption of exons 4 and 5
of the sam68 gene, which encode the functional region of the
KH-type RNA binding domain (Figure 2A). The integrity of
the targeted allele was veriﬁed by Southern blot analysis
(Figure 2B) and by PCR of genomic DNA (unpublished data).
Sam68 transcripts encoded by exons 1 to 5 were absent as
evidenced by RT-PCR (Dataset S2), and Sam68
 /  mice were
devoid of Sam68 protein, as visualized by immunoblotting
with anti-Sam68 AD1 and SC-333 antibodies or control
normal rabbit serum or anti-Sam68 AD1 preabsorbed with
peptide (Figure 2C). SC-333 is a rabbit anti-Sam68 antibody
that was raised against the C-terminal 20 amino acids of
Table 1. Progeny of Sam68 Heterozygote Breeding
Age Genotype
Sam68
þ/þ Sam68
þ/  Sam68
 / 
E18.5 22/88 (25.0%) 48/88 (54.5%) 17/88 (20.5%)
P1 35/124 (28.2%) 75/124 (60.5%) 14/124 (11.3%)
Adult 70/201 (34.8%) 113/201 (56.2) 18/201 (9.0%)
DOI: 10.1371/journal.pgen.0010074.t001
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Sam68 Regulates Osteogenesis and Bone Mass
Synopsis
Osteoporosis is a debilitating bone disease that is characterized by
reduced bone mass and microarchitectural damage, which result in
increased bone fragility and susceptibility to fracture. Peak bone
mass, which is achieved by the age of 30 in humans, has been
identified as a major determinant of resistance or susceptibility to
osteoporosis. The authors generated mice deficient for the Sam68
RNA binding protein, a protein of unknown physiologic function.
The mice develop normally and are protected against bone loss
during aging. Age-related bone loss has long been associated with
an increase in marrow adipocytes, which are derived from the same
mesenchymal lineage as osteoblasts in bone marrow. The authors
showed that Sam68 regulates the differentiation of this mesen-
chymal lineage, such that in its absence, osteoblasts continued to be
generated in aging bone, leading to preservation of bone mass. This
study identifies a physiologic role for Sam68 as a modulator of the
bone marrow stem cell niche and hence of bone metabolism. The
data identify Sam68 as a potential therapeutic target for the
prevention and treatment of age-related bone loss.PLoS Genetics | www.plosgenetics.org December 2005 | Volume 1 | Issue 6 | e74 0678
Sam68 Regulates Osteogenesis and Bone MassSam68 [47]. These data conﬁrmed the generation of a mouse
deﬁcient in Sam68. The genotypes of offspring from
heterozygote intercrosses exhibited a Mendelian segregation
at E18.5 (Table 1). Despite the lack of visible deformity, many
of the Sam68
 /  pups died at birth of unknown causes.
Sam68
þ/- mice were phenotypically normal and Sam68
 / 
pups that survived the perinatal period invariably lived to old
age. Despite evidence that Sam68 mRNA is widely expressed
and phosphorylated in mitosis [41,42], the Sam68
 /  mice did
not develop tumors and showed no immunologic or other
major illnesses. Sam68
 /  mice did, however, have difﬁculty
breeding due to male infertility and the females rarely
provided adequate care to their young.
Sam68 Deficiency Protects Mice from Age-Related Bone
Loss
Src null animals are known to have bone metabolism
defects [48], and since Sam68 is a substrate of Src, we decided
to analyze the Sam68 mice for skeletal abnormalities. Cohorts
of Sam68
þ/þ and Sam68
 /  mice were euthanized at 4 and 12
months of age for skeletal phenotyping. To minimize differ-
ences in the bone phenotype that might arise secondary to
gender or weight differences, we selected age-matched female
mice for these analyses. The female mice demonstrated
similar increases in body weight, although 4-month-old
Sam68
 /  mice weighed less than Sam68
þ/þ mice, and similar
changes in bone lengths in the axial and appendicular
skeleton between 4 and 12 months of age (Table 2). Faxitron
radiography (Faxitron X-ray Corporation, Wheeling, Illinois,
United States) (Figure 3A) and micro–computed tomography
(CT) (Figure 3B) revealed signiﬁcant cortical thinning (arrow)
and a reduction in metaphyseal bone (asterisk) in the distal
femora of 12-month-old Sam68
þ/þ mice compared with 4-
month-old mice of either genotype and 12-month-old
Sam68
 /  mice. Similar reductions in trabecular bone were
shown by Faxitron and micro-CT in the ﬁfth lumbar
vertebrae of the 12-month-old Sam68
þ/þ mice but not in the
Sam68
 /  mice (unpublished data). Total body bone mineral
content (BMC), quantiﬁed with a Lunar PIXImus mouse
densitometer (GE-Lunar, Madison, Wisconsin, United States),
increased in both Sam68
þ/þ and Sam68
 /  mice between 4
months and 12 months of age, but only reached signiﬁcance
in the Sam68
 / mice (Table 2). Similarly, a greater increase in
BMC was seen in the femur and vertebra in the Sam68
 / 
mice. Bone mineral density (BMD) remained constant or
decreased in the wild type mice but increased signiﬁcantly in
the total body and in the femoral and vertebral regions of
Figure 2. Generation of Sam68-Deficient Mice
(A) The genomic organizations of the wild-type and targeted sam68 alleles after homologous recombination are depicted. The location of the DNA
fragment used as a probe for the Southern blot analysis is shown, as well as the sizes of the two BglII fragments detected for wild-type and targeted
sam68 alleles. The targeted allele replaces exon 4 and part of exon 5 of sam68 with a PGK-neomycin cassette.
(B) Southern-blot analysis of genomic DNA from wild-type (þ/þ), heterozygous (þ/ ), and homozygous ( / ) mice. DNA fragments corresponding to
wild-type (4.5 kb) and the targeted (5.5 kb) alleles are illustrated.
(C) Western blot analysis of Sam68 expression. Protein extracts from wild-type, heterozygous, and homozygous cells subjected to immunoblot analyses
using normal rabbit serum, anti-Sam68 AD1 antibody, the peptide antibody AD1 preabsorbed with the immunogenic peptide corresponding to amino
acids 330–348 of mouse Sam68, anti-Sam68 Sc333 antibody that recognizes the C-terminal 20 amino acids of Sam68, and anti-actin antibodies as
loading control. The migration of the molecular mass markers is known on the left in kDa.
DOI: 10.1371/journal.pgen.0010074.g002
Figure 1. Immunohistochemical Localization of Sam68 in Embryonic Mice
(A) Embryonic mice were removed from pregnant dams at E14.5 and E16.5, fixed in 4% paraformaldehyde, and embedded in paraffin. The entire
embryo was immunostained with the AD1 anti-Sam68 antibody and counterstained with methyl green, and the image was captured at 31.2
magnification.
(B) Embryonic soft tissues from the brain, heart and gut were stained with hematoxylin (left) and immunostained with anti-Sam68 antibody (right), and
images were captured at 320 magnification.
(C) Intense anti-Sam68 immunoreactivity was seen in chondrocytes in the nasal septum (panels A–D), in developing vertebra (panels E–H), and in the
femoral epiphysis (panels I–K), as well as in diaphyseal osteoblasts (panel L). Adjacent sections were stained with hematoxylin and eosin (panels A, E,
and I) or with antibody preadsorbed with the immunizing peptide (panels B, F, and J). Sam68 was localized primarily in the nucleus of cells in a variety
of tissues but was also found occasionally in the cytoplasm. Magnification at source 320, except for panels D, H, and L, which were 340. Staining
patterns are representative of three to five embryos.
DOI: 10.1371/journal.pgen.0010074.g001
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Sam68 Regulates Osteogenesis and Bone Massinterest in the Sam68
 /  (Table 2). These data showed that
Sam68
 /  mice continued to thrive and accrue bone in the
axial and appendicular skeleton for longer than 12 months.
T h i sw a si nc o n t r a s tt ot h es i t u a t i o ni na g e - m a t c h e d ,
littermate controls in which a signiﬁcant amount of bone
was lost over the same timeframe.
Three-Dimensional Architecture of Bone Is Preserved in
Aged Sam68
 /  Mice
Bone loss and compromised architecture are characteristic
features of the skeletons of aged C57BL/6 mice and resemble
the clinical features of age-related bone loss in humans that
can predispose an individual to fracture. Quantiﬁcation of
the micro-CT data shown in Figure 3B conﬁrmed the
reduction in bone volume compared with tissue volume
(BV/TV; Figure 4A, left) in the 12-month-old Sam68
þ/þ mice
(hatched bars) compared with 4-month-old mice of both
genotypes (solid bars) and 12-month-old Sam68
 /  mice
(stippled bars). This was associated with a signiﬁcant increase
(p , 0.01; denoted by the asterisks) in the structure model
index, which measures the ratio of plate-like to rod-like
structures (Figure 4A, right). A quantiﬁable increase in the
mean trabecular separation (Tb.Sp) (unpublished data) in 12-
month-old Sam68
þ/þ mice was due to an increase in the
percentage of spaces falling in the range of 350 to 700 lm
(Figure 4B, red hatched line). Trabecular thickness remained
constant among the different groups of mice (unpublished
data). In effect, this meant that there were fewer trabeculae,
rather than equivalent numbers of thin trabeculae, in the 12-
month-old Sam68
þ/þ mice compared with any of the other
groups of mice.
Bone Remodeling Is Preserved in Aged Sam68
 /  Mice
To further deﬁne the mechanisms involved in the
preservation of bone mass in aged Sam68
 /  mice, we
prepared sections from plastic-embedded femora and tibia
to evaluate osteoblast and osteoclast activity (Figure 5). In situ
enzyme histochemical staining for alkaline phosphatase (ALP;
brown stain) activity was used as a biomarker for osteoblasts
and tartrate-resistant ALP (tartrate-resistant acid phospha-
tase [TRAP]; red stain) activity as a marker for osteoclasts.
Little difference was seen between Sam68
þ/þ (Figure 5A and
5B) and Sam68
 / (Figure 5C and 5D) mice at 4 months of age.
ALP- and TRAP-positive cells were reduced in the 12-month-
old Sam68
þ/þ mice (Figure 5E and 5F) and remained
unchanged in 12-month-old Sam68
 /  mice (Figure 5G and
5H). The reduction in both osteoblast and osteoclast activity
in the 12-month-old Sam68
þ/þ mice argued against bone
being lost primarily due to a relative increase in osteoclast
over osteoblast activity, as seen in high turnover disease [49].
Histomorphometric analyses [50] of the long bones (Table
3) corroborated the radiologic evidence of age-related bone
loss. Bone volume (BV/TV), newly formed osteoid (OV/TV),
and mineral apposition rate (MAR) were all signiﬁcantly
reduced in 12-month-old Sam68
þ/þ mice compared with 4-
month-old Sam68
þ/þ mice. These reductions were associated
with a signiﬁcant increase in marrow fat (FV/TV) and
decreased numbers of osteoblasts (nOB/TV) and osteoclasts
(nOC/TV) per tissue volume (Table 3). These results were in
contrast to those of the 12-month-old Sam68
 / mice in which
all histomorphometric parameters, including marrow fat,
resembled those of young mice of either genotype (Table 3).
When cells were expressed as a function of the bone
perimeter (nOB/BP, nOC/BP), there were no statistical
differences and the ratio of osteoblasts to osteoclasts was
similar in all groups of mice (Table 3).
Circulating levels of serum C-telopeptide (sCTX; Roche
Diagnostics, Mannheim, Germany) and ALP showed little
difference among the groups, except for a small decrease in
12-month-old Sam68
 /  mice and (Dataset S3). Serum estro-
gen was signiﬁcantly decreased in all 12-month-old mice
regardless of genotype with a reciprocal increase in inter-
leukin-6 levels (Dataset S3). Given the involvement of leptin
in regulating body and bone mass, serum leptin was measured
in Sam68
þ/þ and Sam68
 /  mice. Twelve-month-old Sam68
 / 
mice had signiﬁcantly lower levels than young and old
Sam68
þ/þ mice and young Sam68
 /  mice (Dataset S3). Taken
together, these observations suggested that preservation of
bone mass in the Sam68
 /  mice was not due primarily to
altered estrogen status but could have been inﬂuenced by
differences in circulating leptin levels.
Table 2. Morphology and Bone Mineral Density in 4- and 12-Month-Old Female Mice
Characteristic Units Genotype
Sam68
þ/þ Sam68
þ/þ Sam68
 /  Sam68
 / 
Age mo (n) 4 (7) 12 (6) 4 (6) 12 (6)
Mean age mo 03.72 6 0.64 12.67 6 2.73 03.83 6 0.26 15.33 6 4.59
Femur length cm 01.37 6 0.07 01.50 6 0.02* 01.23 6 0.08**** 01.45 6 0.04*
Tibia length cm 01.73 6 0.04 01.81 6 0.02* 01.69 6 0.04 01.80 6 0.04*
Lumbar spine cm 01.57 6 0.08 01.94 6 0.08* 01.52 6 0.13 01.86 6 0.06*
Body weight g 21.76 6 2.18 28.98 6 0.97* 19.58 6 2.76 27.83 6 1.81*
Body BMC mg 427.5 6 43.7 482.5 6 52.2 387.5 6 67.8 565.5 6 54.6*
,****
Body BMD mg/cm
2 48.56 6 2.34 48.43 6 1.81 46.73 6 3.35 55.70 6 2.57*
,***
Femur BMC mg 268.7 6 3.28 343.2 6 3.57* 246.3 6 4.05 409.0 6 4.54*
,****
Femur BMD mg/cm
2 64.53 6 3.48 64.42 6 3.00 63.30 6 4.87 74.88 6 2.55*
,***
Vertebra BMC mg 259.6 6 5.9 258.5 6 2.52 245.8 6 3.62 333.7 6 5.11*
,***
Vertebra BMD mg/cm
2 63.87 6 6.23 57.57 6 4.60* 62.88 6 6.81 80.78 6 17.1**
,***
BMC, bone mineral content; BMD, bone mineral density.
*p , 0.01 and **p , 0.05 compared with 4-month-old mice of same genotype.
***p , 0.01 and ****p , 0.05 compared with wild-type mice of the same age.
DOI: 10.1371/journal.pgen.0010074.t002
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Sam68 Regulates Osteogenesis and Bone MassOsteoblast, but Not Osteoclast, Activity Is Altered in
Sam68
 /  Mice Ex Vivo
Maintenance of bone mass during the adult remodeling
cycle is dependent on the coupling of osteoblast to osteoclast
activity, such that there is no net gain or loss of bone [49]. To
further explore the age-related advantage of Sam68
 /  mice
with respect to bone preservation, we examined the func-
tional activity of Sam68
 /  osteoblasts and osteoclasts ex vivo
(Figure 6A and 6B). Cultures of bone marrow stromal cells
harvested from 4-week-old Sam68
 / mice and maintained for
18 days in osteoblast differentiation medium demonstrated
more intense staining for ALP at 6 days (unpublished data)
and 18 days (Figure 6A), and more mineralized nodules at 18
days, than the Sam68
þ/þmice, even though similar amounts of
ﬁbroblast colony-forming units (CFU-F) were observed
(Figure 6A and unpublished data). RT-PCR analysis of
molecular markers of osteoblast differentiation (Dataset S2)
revealed similar increases over time in RNA from Sam68
þ/þ
and Sam68
 /  mice, although type I collagen appeared to be
up-regulated at both timepoints in the Sam68
 /  mice. Short-
term cultures of mature osteoclasts released from the crushed
long bones of Sam68
þ/þ and Sam68
 /  mice stained equally
well for TRAP and excavated approximately equal numbers
of pits of equal size in dentin slices, as visualized by scanning
electron microscopy (Figure 6B). These ﬁndings suggest that
the osteoclasts may not be the primary defect in Sam68
 / 
mice, as they are in Src null mice [48].
The Absence of Sam68 Prevents Adipocyte Differentiation
and Promotes Osteoblast Differentiation
It is well recognized that bone marrow stromal cells give
rise to both osteoblasts and adipocytes and that age-related
Figure 4. Quantitative Micro-CT of Trabecular Bone Composition and
Architecture
(A) Bone volume/tissue volume (BV/TV) and structure model index (SMI)
were calculated on the femur and fourth lumbar vertebra of six or seven
mice in each group using 3D Creator software supplied with the Skyscan
instrument. Results expressed as the mean 6 SD showed significant
differences (p , 0.01) between 4-month-old Sam68
þ/þ mice (solid black)
and 12-month-old Sam68
þ/þ mice (hatched black) but not between 4-
month-old Sam68
 / mice (solid white) and 12-month-old Sam68
 / mice
(stippled white).
(B) The distance between trabeculae was reflected in a shift to the right
of the distribution curves for 12-month-old Sam68
þ/þ. Solid black ¼ 4-
month-old Sam68
þ/þ; hatched black¼12-month-old Sam68
þ/þ; solid red
¼ 4-month-old Sam68
 / ;s t i p p l e dr e d¼ 12-month-old Sam68
 / .
The asterisks denote p , 0.01.
DOI: 10.1371/journal.pgen.0010074.g004
Figure 3. Radiologic Assessment of the Femur of Young and Old
Sam68
þ/þ and Sam68
 /  Mice
(A) Mice were given a lethal dose of anesthetic at the indicated times,
and contact radiographs of the distal femora were obtained on a
Faxitron MX20 equipped with an FPX-2 Imaging system. Representative
radiographs of the distal femur of Sam68þ/þ (þ/þ) and Sam68 /  ( / )
mice revealed comparable radiopacity at 4 months (left). At 12 months
(right), cortical thinning (arrow) and radiolucency (asterisk) were
apparent in the distal femur of þ/þ mice but not  /  mice.
(B) Bones were dissected free of soft tissue and fixed overnight in 4%
paraformaldehyde before scanning on a Skyscan 1072 static instrument
equipped with 3D Creator analytical software. Representative three-
dimensional re-constructions and two-dimensional cross-sectional scans
demonstrated similar architecture in the distal femur of Sam68
þ/þ (þ/þ)
and Sam68
 / ( / ) mice. In keeping with the results from Faxitron x-ray,
trabecular bone (asterisk) and cortical thickness (arrow) were reduced in
the femur of 12-month-old þ/þ mice compared with all other groups.
The images are representative of those from five to seven animals in
each group.
DOI: 10.1371/journal.pgen.0010074.g003
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Sam68 Regulates Osteogenesis and Bone MassFigure 5. Histologic Analysis of Undecalcified Bone from Sam68
þ/þ and Sam68
 /  Mice
Sections of tibia fixed in 4% paraformaldehyde and embedded in plastic were stained for ALP (A–C, E–G) activity to identify osteoblasts or for TRAP (B–
D, F–H) activity to identify osteoclasts. Staining patterns were similar in 4-month-old Sam68
þ/þ (A and B), 4-month-old Sam68
 /  (C and D), and 12-
month-old Sam68
 /  (G and H) mice compared with 12-month-old Sam68
þ/þ mice (E and F). Magnification at source, left panels310 and right panels
340. Micrographs are representative of those taken from five to seven sections in each group of animals.
DOI: 10.1371/journal.pgen.0010074.g005
Table 3. Histomorphometric Analysis of Long Bones from 4- and 12-Month-Old Mice
Characteristic Unit Genotype
Sam68
þ/þ Sam68
þ/þ Sam68
 /  Sam68
 / 
Age mo (n) 4 (7) 12 (6) 4 (6) 12 (6)
BV/TV % 13.42 6 5.92 2.51 6 1.72* 18.65 6 6.58 18.37 6 14.20****
OV/TV % 0.67 6 0.25 0.10 6 0.08* 1.14 6 0.57 0.68 6 0.42***
MAR lm/d 1.45 6 0.93 0.99 6 0.62* 1.00 6 0.54**** 0.67 6 0.36****
FV/TV % 1.94 6 0.65 25.42 6 4.33* 2.50 6 0.82 2.48 6 1.85***
nOb/TV n/mm 62.00 6 19.87 6.50 6 6.17* 79.66 6 25.48 64.61 6 31.68***
nOc/TV n/mm 23.59 6 0.01 2.08 6 2.07* 33.37 6 20.79 22.60 6 10.68***
nOb/BP n/mm 8.61 6 1.98 6.40 6 5.34 9.04 6 2.13 11.84 6 4.69
nOc/BP n/mm 3.13 6 0.77 2.15 6 2.04 3.49 6 1.25 4.10 6 1.82
Ct.Wi mm 0.19 6 0.01 0.14 6 0.01* 0.17 6 0.01 0.16 6 0.03
Tb.Th lm 31.33 6 6.38 34.98 6 21.33 34.00 6 8.92 44.5 6 39.3
Tb.Sp lm 282 6 130 562 6 264* 229 6 172 400 6 370
BV/TV, bone volume/tissue volume; Ct.Wi, cortical width; FV/TV, marrow fat volume/tissue volume; MAR, mineral apposition rate; nOb/BP, number of osteoblasts/bone perimeter; nOb/TV, number of osteoblasts/tissue volume; nOc/TV, number
of osteoclasts/tissue volume; Oc/BP, number of osteoclasts/bone perimeter; OV/TV, osteoid volume/tissue volume; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness [50].
*p , 0.01 and **p , 0.05 compared with 4-month-old mice of same genotype.
***p , 0.01 and ****p , 0.05 compared with wild-type mice of the same age.
DOI: 10.1371/journal.pgen.0010074.t003
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Sam68 Regulates Osteogenesis and Bone Massbone loss is accompanied by an increase in differentiation
down the adipocyte lineage [22]. Therefore, the loss of Sam68
could inﬂuence the bone marrow stromal cells to differ-
entiate along the osteogenic versus the adipogenic pathway.
Alternatively, the loss of Sam68 could indirectly regulate
bone mass as a general disturbance of neuroendocrine
control as was shown when leptin and the sympathetic
nervous system axis were shown to negatively regulate bone
mass [8]. To conﬁrm a role for Sam68 in the regulation of
adipocyte differentiation, we isolated primary MEFs from
14.5-day-old Sam68
þ/þ and Sam68
 /  embryos. The primary
Sam68
 / MEFs were differentiated into adipocytes in vitro in
culture medium containing 5 lM pioglitazone to induce
adipogenesis. Cells at days 0, 4, 6, and 12 were stained with Oil
red O to monitor adipogenesis. Adipogenesis was more
pronounced in the wild-type MEFs cultures than in the
Sam68
 /  MEFs, consistent with the positive role of endoge-
nous Sam68 in adipocyte differentiation (Figure 7). The
expression of key transcription factors including the PPARc
and KLF5 was impaired in Sam68
 /  differentiated MEFs
compared with Sam68
þ/þ MEFs, consistent with impaired
adipogenesis in the absence of Sam68 (Figure 7). These data,
together with data conﬁrming a lean phenotype in Sam68
 / 
mice (N. Torabi and S. Richard, unpublished data), support
the hypothesis that Sam68 modulates the differentiation of
mesenchymal cells.
To further examine this phenotype in a cell autonomous
system, we chose the embryonic mesenchymal multipotential
progenitor cells C3H10T1/2. The addition of BMP-2 induced
osteoblast differentiation, as evidenced by an approximately
400-fold increase in expression of the osteocalcin (OCN) gene
[51]. Populations of C3H10T1/2 cells stably transfected with
either pSuper-retro (control) and pSuper-retro harboring a
short hairpin against Sam68 (Sam68sh) were selected with
puromycin. The expression of Sam68 was reduced by
approximately 80% as evidenced by immunoblot analyses
using b-actin as a loading control (Figure 8A). Osteoblast
differentiation was induced in cultures expressing pSuper-
retro or pSuper-retro Sam68sh by addition of BMP-2 to the
culture medium. . The expression of OCN and b-actin mRNAs
was examined by semiquantitative RT-PCR and the Sam68sh-
expressing cells displayed a more pronounced osteoblast
phenotype compared with control cells, as assessed by the
expression of OCN (Figure 8B).
Given the apparent enhancement of mineralized nodule
formation by Sam68
 / bone marrow stromal cells ex vivo and
the phenotype observed with short hairpin RNA (shRNA)-
treated C3H10T1/2, we stained sections of bone from 4- and
12-month-old mice for evidence of changes in marrow
adiposity. Figure 9 shows sections of undecalciﬁed bone from
4- and 12-month-old Sam68
þ/þ and Sam68
 /  mice stained
with von Kossa and toluidine blue to show mineralized tissue
(Figure 9A, black) and marrow adipocytes (Figure 9B, white)
and left unstained to show ﬂuorochrome labeling of the
Figure 6. Ex Vivo Activity of Sam68
þ/þ and Sam68
 /  Osteoblasts and Osteoclasts
Marrow stromal cells were isolated from the long bones of juvenile mice and maintained under conditions that promote osteoblast differentiation.
(A) Cultures were fixed in 4% paraformaldehyde after 6 or 18 days and stained in situ for ALP activity and with silver nitrate (von Kossa) to detect
mineralized nodules. Sam68
 /  cultures stained more intensely for ALP at early and late time points and produced significantly more mineralized
nodules after 18 days. Asterisks represent p , 0.01.
(B) Primary osteoclasts were isolated from the crushed long bones of the same mice and plated on glass coverslips or on dentin slices to quantify
numbers and activity, respectively. Osteoclasts were identified as cells with three or more nuclei that stained positive for TRAP activity (upper) and
excavated pits in dentin slices, as demonstrated by SEM (lower, bar ¼ 20 lm). No statistical differences were observed either in the number of TRAP-
positive cells or in their resorptive activity.
DOI: 10.1371/journal.pgen.0010074.g006
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Sam68 Regulates Osteogenesis and Bone Massmineralizationfronts(Figure9C).Twelve-month-old Sam68
þ/þ
mice showed a noticeable decrease in trabecular bone (Figure
9A), which was associated with a signiﬁcant increase in
marrow adiposity (Figure 9B) and with the two ﬂuorochrome
labels superimposed upon one another (Figure 9C). In
contrast, the bones of 12-month-old Sam68
 /  mice appeared
similar to those of the 4-month-old mice of either genotype.
These data demonstrate that Sam68 regulates the differ-
entiation of bone marrow mesenchymal cells to promote
adipocyte differentiation and inhibit osteoblast differentia-
tion in aging bone.
Discussion
The present study provides evidence that a physiologic role
of Sam68 is to modulate bone marrow mesenchymal stem
Figure 7. Ex Vivo Adipogenesis Analysis of Sam68
 /  Mouse Embryonic Fibroblasts
MEFs were isolated from mouse embryos at embryonic day 14.5. Equal number of MEFs from Sam68
þ/þand Sam68
 / was plated on glass cover slips in
24 well-plates. Adipocyte differentiation was carried out at indicated times by the addition of complete media containing the pioglitazone.
(A) Cultures were fixed in 4% paraformaldehyde and stained with Oil Red O to detect the fat droplets stored in adipocytes and photographed (top). The
cell images were magnified 310 and 320 as indicated.
(B) RT-PCR was carried out on total cellular RNA isolated after differentiation of the MEFs for day 0, 2, 4, 6, and 12. The DNA fragments were visualized on
agarose gels stained with ethidium bromide. The expression of adipogenic markers C/EBPb, C/EBPd, PPARa, and KLF5 was examined as well as the
expression of controls including Sam68, b-actin, and GAPDH.
DOI: 10.1371/journal.pgen.0010074.g007
Figure 8. Enhanced Osteogenic Differentiation of the C3HT101/2 Embryonic Cell Line Depleted of Endogenous Sam68
(A) C3HT101/2 cells transfected with an empty vector (pSuper-retro) or a vector containing an shRNA (Sam68 shRNA) were selected with puromycin,
and knockdown populations depleted of Sam68 were identified. The reduction in Sam68 protein was analyzed by immunoblotting with anti-Sam68
(AD1) antibody and anti–b-actin antibodies as loading controls.
(B) Osteogenic differentiation was carried out with conditioned medium containing BMP-2 for the indicated times. To assess the level of osteogenic
differentiation in these cells, expression of late osteoblast marker, osteocalcin (OCN), was analyzed by RT-PCR and compared with b-actin and GAPDH
controls. The DNA fragments were visualized by agarose gel stained with ethidium bromide.
DOI: 10.1371/journal.pgen.0010074.g008
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 /  mice developed normally and con-
tained similar bone mass compared with wild-type litter-
mates. Aged (12 months) Sam68
 / mice displayed a high bone
mass phenotype compared with Sam68
þ/þ littermates. The
wild-type littermates underwent age-related bone loss that
occurs naturally in mammals, while the Sam68
 /  animals
preserved their bone mass with aging. The differentiation of
bone marrow stem cells isolated from Sam68
 /  mice and
embryonic mesenchymal multipotential progenitor cells
C3H10T1/2 treated with Sam68 shRNA resulted in a more
pronounced osteoblast differentiation. These ﬁndings dem-
onstrate that the loss of Sam68 enhances osteoblast differ-
entiation. The converse was also true, as MEFs isolated from
Sam68
 /  animals were impaired in their ability to undergo
adipocyte differentiation compared with Sam68
þ/þ MEFs.
These ﬁndings suggest that a physiologic role for Sam68 is to
regulate the balance between adipogenic and osteogenic
differentiation of the bone marrow mesenchymal.
Sam68 protein expression was observed throughout the
developing mouse embryo, in keeping with previous reports
that identiﬁed the Sam68 mRNA to be widely expressed [38].
We observe Sam68 staining in the brain, heart, and intestine
(see Figure 1) as well as liver, skin, and kidney (unpublished
data) of late-stage embryos. This expression pattern is
consistent with previous work that has observed Sam68 in
neurons [52] and as a substrate of the intestinal SIK/breast
tumor kinase [43]. The expression of Sam68 was not altered in
aging bone marrow stromal cells or in senescencing WI-38
cells (unpublished data). The presence of Sam68 in chon-
drocytes, osteoblasts and osteoclasts in developing cartilage
and bone predicted a pivotal role for the protein in skeletal
development.
The Sam68
 /  mice were generated using a traditional
targeting approach where the functional KH domain was
deleted and approximately one third of the Sam68
 /  mice
survived to adulthood with no apparent defects. One
explanation for this phenomenon is that Sam68 function is
sub-served by one or more of its family members during
development such as SLM-1 and SLM-2 [47]. Alternatively,
Sam68 is not required during embryonic development.
However, two thirds of the Sam68
 / , but not the Sam68
þ/-
pups, were killed by their Sam68
þ/- mothers. These ﬁndings
suggest that the mothers are able to detect a subtle defect/
difference that we cannot. Adult Sam68
 /  mice live a normal
life span of approximately two years. The Sam68
 /  males
were sterile and the Sam68
 /  females provided inadequate
Figure 9. Old Sam68
 /  Mice Are Protected from the Development of Fatty Bone Marrow
Sections of undecalcified bone were stained with von Kossa and toluidine blue and images captured at original magnifications of32 (A),340 (B and C)
to evaluate mineralized tissue (A, black), marrow adipocytes (B, white), and the mineralization fronts (C, yellow and green). The 12-month-old Sam68
þ/þ
bone demonstrated a significant reduction in bone (A) and increase in marrow adipocytes (B) and a decrease in the distance between two consecutive
fluorochrome labels (C). Magnification at source was 340. Micrographs are representative of four to six screened in each group of animals.
DOI: 10.1371/journal.pgen.0010074.g009
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Sam68 Regulates Osteogenesis and Bone Masscare to their young, but the pups were not scattered and
neglected as observed with FosB
 /  mice [53]. Serum levels of
estrogen decreased in aging Sam68
 /  females as expected;
however, the leptin levels decreased in aged Sam68
 / females.
The aged Sam68
 /  females were not obese and actually
weighed less than the littermate controls (see Table 2).
Moreover, their appetite was not altered with aging (N.
Torabi and S. Richard, unpublished data), suggesting that the
observed leptin reduction was not recreating ob/ob-like
phenotypes related to weight, appetite and female sterility
[54].
The skeletal phenotyping of cohorts of Sam68
þ/þ and
Sam68
 /  mice showed that bone mass was preserved in aged
Sam68
 /  mice. Traditional histology and histomorphometry
suggested that the mechanism involved preservation of
osteoblast and osteoclast activity. The documented role of
the Sam68 regulatory protein, Src, in osteopetrosis led us to
investigate the morphology and activity of Sam68
 /  osteo-
clasts ex vivo. The Src tyrosine kinase was shown to play a role
in bone remodeling when Src
 /  mice died at 6 months of age
with an osteopetrotic phenotype [48] and the defect was
attributed to defective osteoclast function [55 59]. We
therefore cultured mature osteoclasts harvested from
Sam68
þ/þ and Sam68
 /  mice ex vivo on dentin slices to
quantify their resorptive capacity. The fact that Sam68
 / 
osteoclasts looked and acted like Sam68
þ/þ osteoclasts ex vivo
and in vivo made it unlikely that this was the primary source
of the difference in bone metabolism in 12-month-old
Sam68
 /  mice. The fact that the CTX levels were lower in
young and old Sam68
 /  mice suggested that there is reduced
bone resorption compared with wild-type littermate controls.
However, this reduction in bone resorption occurred with
normal osteoclast activity, as assessed by in vitro culturing.
These observations are consistent with the Sam68
 /  mice
having a youth-like bone phenotype. However, it is still
possible, that a mild impairment in Sam68
 /  mice osteoclast
function may manifest itself later in life in overall accumu-
lation of bone and this will require further detailed studies.
Ex vivo differentiation of primary bone marrow stromal
cells, harvested from Sam68
þ/þ and Sam68
 /  mice, down the
osteoblast lineage revealed an osteogenic advantage in the
cultures of cells derived from the Sam68
 /  mice. It will be
important to demonstrate that a similar effect is observed
using primary bone marrow stromal cells from aged Sam68
 / 
mice. Similar ﬁndings were observed when embryonic
mesenchymal multipotential progenitor cells C3H10T1/2
treated with Sam68 shRNA, were differentiated into osteo-
blasts with BMP2. Our ﬁndings that aged Sam68
 /  mice do
not develop fatty bone marrow and that MEFs derived from
Sam68
 /  mice have impaired adipocyte differentiation,
indicate that Sam68 regulates both adipocyte and osteoblast
differentiation. These ﬁndings identify Sam68 as the ﬁrst
RNA binding protein to regulate mesenchymal cell differ-
entiation and the challenge will be to identify the speciﬁc
RNA targets that it regulates during this process. The fact
that osteoblast function is altered in Src
 /  mice [60,61] raises
the possibility that preservation of bone mass in the Sam68
 / 
mice could be linked with and regulated by Src.
The pathway by which leptin regulates bone resorption was
identiﬁed to involve the sympathetic nervous system relaying
to the osteoblasts via the b-adrenergic pathway leading to the
release of growth factors including RANKL that causes the
osteoclasts to thrive [8,18–20]. The lowering of leptin levels in
aged Sam68
 /  mice is consistent with these mice having a
high bone mass compared with their aged littermates. These
data would suggest that the leptin-sympathetic pathway is
unaltered in Sam68
 /  mice and that the lowering of leptin
may explain the lower levels of CTX in the serum of Sam68
 / 
mice. These ﬁndings suggest that Sam68 may be regulating
bone metabolism at two different levels: (1) the absence of
Sam68 results in lower leptin levels that may reduce bone
resorption via the sympathetic nervous system and (2) the
absence of Sam68 favors osteoblast, rather than adipocyte,
differentiation.
In conclusion, our data deﬁne a physiologic role for Sam68
in bone metabolism and bone marrow mesenchymal stem cell
differentiation. The bone phenotype observed in Sam68
 / 
mice imply that inhibitors of Sam68 could prevent age-
related bone loss. Furthermore, the results also suggest that
Sam68 expression levels, hypomorphism, and mutations in
humans may inﬂuence susceptibility to marrow adipocyte
accumulation and osteoporosis. Our ﬁndings also identify a
new animal model to study aging bone loss.
Materials and Methods
Histologic, immunohistochemical, and histomorphometric analy-
ses. All analyses were performed essentially as described previously
[62,63]. Brieﬂy, embryonic mice were removed from timed pregnant
dams at E14.5 and E16.5 and ﬁxed intact for 36 h in 4%
paraformaldehyde, rinsed thoroughly in PBS, and processed for
parafﬁn embedding. Serial 4-lm sections were cut on a modiﬁed
Leica RM 2155 rotary microtome (Leica Microsystems, Richmond
Hill, Ontario, Canada), stained with a 1:600 dilution of the AD1 anti-
Sam68 antibody [46] and counterstained with either methyl green or
hematoxylin.
Adult mice were given an intraperitoneal injection of 30 mg/kg
calcein at 7 days and 30 mg/kg tetracycline at 2 days prior to sacriﬁce
to label actively mineralizing surfaces. After overnight ﬁxation in 4%
paraformaldehyde and rinsing in PBS, the left femur and tibia were
embedded in polymethylmethacrylate (MMA) or a mixture of 50%
MMA and 50% glycolmethacrylate (GMA). Serial 4- to 6-lm sections
of MMA-embedded tissues were left unstained or stained with von
Kossa and toluidine blue or with toluidine blue alone, while 4-lm
MMA-GMA sections were stained for TRAP and ALP activity. Images
were captured using a Leica DMR microscope (Leica Microsystems)
equipped with a Retiga 1300 camera (Qimaging, Burnaby, British
Columbia, Canada) and the primary histomorphometric data
obtained using Bioquant Nova Prime image analysis software
(Bioquant Image Analysis Corp, Nashville, Tennessee, United States).
Nomenclature and abbreviations conform to those recommended by
the American Society for Bone and Mineral Research [50].
Generation of mice with targeted disruption of the sam68 gene. A k
bacteriophage clone encompassing Sam68 exons 3 to 9 was isolated
from a 129/SvJ genomic library using full-length Sam68 cDNA as a
probe. XbaI-digested Sam68 genomic DNA fragments of 4 kb
(encompassing exon 4 and part of exon 5) and 3kb (spanning part
of exon 5 and exon 6) were subcloned in Bluescript SK resulting in
pBS4 and pBS3, respectively. A DNA fragment was ampliﬁed from
pBS4 with the following oligonucleotides (59-AAT GTC TAG AAA
CAA CTC ATA TAC AGA C-39) and the universal primer. The XbaI-
digested 1-kb DNA fragment was subcloned in the XbaI site of pPNT
(a gift from Andrew Karaplis, McGill University, Montre ´al, Quebec,
Canada). The 3-kb fragment from pBS3 was ampliﬁed by PCR with
(59-GGG ATG CGG CCG CTC TAG AAT TGT CCT ACT TGA ACG
G-3’) and (59-CGG TGG CGG CCG CTG TCG ACC TGA GTA ACA
TTT CTT A-39) and subcloned in the NotI site of pPNT. The targeting
vector pPNT-Sam68 replaces exon 4 and part of exon 5 with a
neomycin-resistant gene cassette. An SalI site was introduced at the 39
end of the 3-kb DNA fragment and was used to linearize the plasmid
for electroporation into embryonic stem (ES) cells. Approximately
1,000 ES colonies were screened and two clones were identiﬁed that
contained the Sam68 mutant allele, as determined by Southern
blotting. Targeted ES cells were injected into 3.5-day-old BALB/c
blastocysts and were transferred into CD-1 foster mothers, and
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mice. Germ line transmission was achieved and the mice were
maintained in C57BL/6 background. The mice used for this study
represent mice that were backcrossed in C57BL/6 between three and
eight generations; in addition, we maintained the mice in the 129/SvJ
strain and observed a similar phenotype.
Genotyping and immunoblot analyses. All mouse procedures were
performed in accordance with McGill University guidelines, which
are set by the Canadian Council on Animal Care. Genomic DNA was
isolated from tail biopsies and analyzed by Southern blotting and
genomic PCR analysis. The DNA fragment utilized as the probe for
the Southern blotting analysis was ampliﬁed with the following two
oligonucleotides (59-AAG CCT TTA CTG GTT GTG T-39) and (59-
CTT GAA ACG CAC CGT AGG CT-39). The wild-type sam68 allele
was identiﬁed by genomic PCR using the following oligonucleotides
59-AAA TCC TAA CCC TCC TCA GTC AG-39 and 59-GAT ATG ATG
GAT GAT ATC TGT CAG-39. The sam68-targeted allele was identiﬁed
by genomic PCR using the following oligonucleotides 59-CTT GGG
TGG AGA GGC TAT TCG-39 and 59-GTC GGG CAT GCG CGC CTT
GAG C-39.
Radiology and serum biochemistry on Sam68
þ/þ and Sam68
 / 
mice. Radiography, BMD, and micro-CT were performed essentially
as described previously [63]. Mice were administered a lethal dose of
anesthetic at the indicated times, exsanguinated, and imaged using a
Faxitron MX20 equipped with an FPX-2 Imaging system (Dalsa
Medoptics, Waterloo, Ontario, Canada). Body fat, BMC, and BMD
were evaluated using a Lunar PixiMUS 1.46 (GE-Lunar, Madison,
Wisconsin, United States). Morphometric parameters were deter-
mined on anesthetized mice at the time of sacriﬁce by direct
measurement or from the Faxitron radiograph.
Micro-CT was performed on the left femur and fourth lumbar
vertebra after removal of soft tissues and overnight ﬁxation in 4%
paraformaldehyde. The distal metaphysis was scanned with a Skyscan
1072 micro-CT instrument (Skyscan, Antwerp, Belgium). Image
acquisition was performed at 100 kV and 98 lA, with a 0.98 rotation
between frames. The two-dimensional images were used to generate
three-dimensional reconstructions to obtain quantitative data with
the 3D Creator software supplied with the instrument.
Serum biochemistry (ALP, Ca, PO4, Mg) was determined at the
Rodent Diagnostics Lab (McGill University, Montre ´al, Quebec,
Canada) using routine automated techniques. Commercial assays
were used to determine serum levels of CTX (RatLaps ELISA, Nordic
Bioscience), 17b estradiol (IBL Immuno-Biological, Hamburg, Ger-
many), leptin (R & D Systems, Minneapolis, Minnesota, United States),
and interleukin-6 (R & D Systems).
Ex vivo assessment of osteoblast and osteoclast activity. Bone
marrow was ﬂushed from the tibia and femora of juvenile 4-week-old
Sam68
þ/þ and Sam68
 /  mice to obtain stromal cells that were
maintained in differentiation medium for 6 or 18 days as described
[63]. Cultures were stained in situ for ALP activity and with von Kossa
stain to detect mineralized nodules. Total RNA was harvested from
parallel cultures for RT-PCR analysis of osteoblast-related gene
expression over time as described previously [63].
Osteoclasts were isolated from the crushed long bones of juvenile
Sam68
þ/þ and Sam68
 /  mice and used for quantitative studies as
described [64]. Brieﬂy, cells were plated on glass coverslips or on
dentin slices in 24-well cluster plates for assessment of cell number
and pit number, respectively. Cover slips were immersed in 4%
paraformaldehyde and stained for TRAP activity after 2 h. Dentin
slices were left for 28 h before removing the cells with 1 M
ammonium hydroxide and air drying before coating with sputter
Au-Pd and examination with scanning electron microscopy (McGill
Electron Microscopy Centre). Light microscope images were cap-
tured using a Leica DMR microscope equipped with a Retiga 1300
camera. Quantitative analyses were performed using Adobe Photo-
shop and the data presented as the mean 6 SD of two or three
independent experiments. Statistical comparisons were made using
the Student’s t test.
Preparation of mouse embryonic ﬁbroblast and induction of
adipocyte differentiation. MEFs were prepared from 14.5-day-old
embryos. Only early-passage MEFs were used for the experimental
studies, and induction of adipocyte differentiation was carried out
according to the methods previously described [30]. Cultured cells
were stained with Oil Red O as described [29].
RNA preparation and RT-PCR to assess adipogenesis in Sam68
 / 
MEFs. Total cellular RNA was prepared by TRIzol reagent according
to the manufacturer’s protocol (Invitrogen, Carlsbad, California,
United States). Total RNA (1 lg) was reverse-transcribed, and cDNA
samples were subjected to PCR. RT-PCR was normalized by the
transcriptional level of GAPDH. The following 59 and 39 primers were
used to evaluate adipogenic differentiation: KLF5: 5’-AGA CAA GCT
GAG ATG CTG C-39,5 9-GGC AAA CCT CCA GTC GC-39; PPARc:5 9-
GTG CGA TCA AAG TAG AAC CTG C-39,5 9-CCT ATC ATA AAT
AAG CTT CAA TCG-39; b-Actin: 59-TAG GCG GAC TGT TAC TGA
GC-39,5 9-AGC CTT CAT ACA TCA AGT TGG-39; and Sam68: 59-
GTG GAG ACC CCA AAT ATG CCC A-39 and 59-AAA CTG CTC
CTG ACA GAT ATC A-39.
Sam68 down-regulation using Sam68sh. To generate an shRNA, 64-
base duplex DNA nucleotides were purchased from Invitrogen. This
fragment comprised 19 base residues speciﬁc to mouse Sam68
(GATCCCC AAGATGACGAGGAGAATTATTCAAGAGA
TAATTCTCCTCGTCATCTT TTTTTGGAAA). This fragment was
cloned into pSUPER retro (OligoEngine, Seattle, Washington, United
States). Transfections were performed using LipofectAMINE Plus
(Invitrogen) with cloned DNA fragment or empty vector. At 48 h after
transfection, populations were selected for 2.5 lg/ml puromycin and
the knockdown observed by immunoblotting with anti-Sam68 (AD1)
antibody.
Osteogenic differentiation analysis of C3HT101/2 cells. For
osteogenic differentiation, C3HT101/2 (ATCC) cells were incubated
in 48-well tissue culture plates at 1.25 3 10
4 cells/cm
2 . After 24-h
incubation, the culture media were changed to fresh media
containing 300 ng/ml BMP-2 (Sigma, St. Louis, Missouri, United
States). Total cellular RNA was prepared as described above, and
osteocalcin, b-actin, and GAPDH gene expression at indicated times
after BMP-2 treatment was quantiﬁed by RT-PCR.
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